Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.
COVID-19
Group testing
SARS CoV-2
Journal
American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470
Informations de publication
Date de publication:
05 05 2020
05 05 2020
Historique:
pubmed:
19
4
2020
medline:
8
5
2020
entrez:
19
4
2020
Statut:
ppublish
Résumé
To establish the optimal parameters for group testing of pooled specimens for the detection of SARS-CoV-2. The most efficient pool size was determined to be five specimens using a web-based application. From this analysis, 25 experimental pools were created using 50 µL from one SARS-CoV-2 positive nasopharyngeal specimen mixed with 4 negative patient specimens (50 µL each) for a total volume of 250 µL. Viral RNA was subsequently extracted from each pool and tested using the CDC SARS-CoV-2 RT-PCR assay. Positive pools were consequently split into individual specimens and tested by extraction and PCR. This method was also tested on an unselected group of 60 nasopharyngeal specimens grouped into 12 pools. All 25 pools were positive with cycle threshold (Ct) values within 0 and 5.03 Ct of the original individual specimens. The analysis of 60 specimens determined that 2 pools were positive followed by identification of 2 individual specimens among the 60 tested. This testing was accomplished while using 22 extractions/PCR tests, a savings of 38 reactions. When the incidence rate of SARS-CoV-2 infection is 10% or less, group testing will result in the saving of reagents and personnel time with an overall increase in testing capability of at least 69%.
Identifiants
pubmed: 32304208
pii: 5822023
doi: 10.1093/ajcp/aqaa064
pmc: PMC7188150
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-718Subventions
Organisme : NIAID NIH HHS
ID : R01 AI121351
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : UpdateOf
Informations de copyright
© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
J Clin Microbiol. 2012 Mar;50(3):891-6
pubmed: 22205820
Vox Sang. 2011 Jan;100(1):92-8
pubmed: 21175659
Am J Clin Pathol. 2020 Apr 15;153(5):567-570
pubmed: 32190890
Stat Med. 2019 Oct 30;38(24):4912-4923
pubmed: 31469188